Spots Global Cancer Trial Database for pleomorphic rhabdomyosarcoma

Every month we try and update this database with for pleomorphic rhabdomyosarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall	NCT03651375	Sarcoma Fibrosarcoma Leiomyosarcoma Liposarcoma Myosarcoma Histiocytic Sar... Synovial Sarcom... Lymphangiosarco... Malignant Perip... Myxofibrosarcom... Myxoid Liposarc... Undifferentiate... Pleomorphic Lip... Undifferentiate... Dedifferentiate... Pleomorphic Rha... Malignant Trito...	Sequential chem... Hypofractionate...	18 Years - 100 Years	Maria Sklodowska-Curie National Research Institute of Oncology
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma	NCT06277154	Leiomyosarcoma Liposarcoma Synovial Sarcom... Angiosarcoma Undifferentiate... Epithelioid Sar... Malignant Perip... Fibrosarcoma Pleomorphic Rha... Endometrial Str... Desmoplastic Sm...	MASCT-I Doxorubicin Ifosfamide	18 Years - 70 Years	HRYZ Biotech Co.
Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma	NCT04420975	Leiomyosarcoma Malignant Perip... Myxofibrosarcom... Pleomorphic Rha... Resectable Dedi... Resectable Soft... Resectable Undi... Soft Tissue Fib... Spindle Cell Sa... Stage I Retrope... Stage I Soft Ti... Stage IA Retrop... Stage IA Soft T... Stage IB Retrop... Stage IB Soft T... Stage II Retrop... Stage II Soft T... Stage III Retro... Stage III Soft ... Stage IIIA Retr... Stage IIIA Soft... Stage IIIB Retr... Stage IIIB Soft... Storiform-Pleom... Synovial Sarcom... Undifferentiate... Undifferentiate... Undifferentiate... Undifferentiate... Undifferentiate...	Definitive Surg... Nanoplexed Poly... Nivolumab Radiation Thera...	18 Years -	Jonsson Comprehensive Cancer Center
Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery	NCT03009201	Advanced Soft T... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Angi... Metastatic Epit... Metastatic Fibr... Metastatic Lipo... Metastatic Mali... Metastatic Myxo... Metastatic Soft... Metastatic Syno... Metastatic Undi... Myxofibrosarcom... Pleomorphic Rha... Stage III Soft ... Stage IV Soft T... Undifferentiate... Unresectable Le... Unresectable Li... Unresectable Ma... Unresectable So... Unresectable Sy... Unresectable Un...	Doxorubicin Hyd... Laboratory Biom... Pharmacological... Ribociclib	12 Years -	OHSU Knight Cancer Institute
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma	NCT06277154	Leiomyosarcoma Liposarcoma Synovial Sarcom... Angiosarcoma Undifferentiate... Epithelioid Sar... Malignant Perip... Fibrosarcoma Pleomorphic Rha... Endometrial Str... Desmoplastic Sm...	MASCT-I Doxorubicin Ifosfamide	18 Years - 70 Years	HRYZ Biotech Co.
Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery	NCT03009201	Advanced Soft T... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Angi... Metastatic Epit... Metastatic Fibr... Metastatic Lipo... Metastatic Mali... Metastatic Myxo... Metastatic Soft... Metastatic Syno... Metastatic Undi... Myxofibrosarcom... Pleomorphic Rha... Stage III Soft ... Stage IV Soft T... Undifferentiate... Unresectable Le... Unresectable Li... Unresectable Ma... Unresectable So... Unresectable Sy... Unresectable Un...	Doxorubicin Hyd... Laboratory Biom... Pharmacological... Ribociclib	12 Years -	OHSU Knight Cancer Institute
Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery	NCT03009201	Advanced Soft T... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Angi... Metastatic Epit... Metastatic Fibr... Metastatic Lipo... Metastatic Mali... Metastatic Myxo... Metastatic Soft... Metastatic Syno... Metastatic Undi... Myxofibrosarcom... Pleomorphic Rha... Stage III Soft ... Stage IV Soft T... Undifferentiate... Unresectable Le... Unresectable Li... Unresectable Ma... Unresectable So... Unresectable Sy... Unresectable Un...	Doxorubicin Hyd... Laboratory Biom... Pharmacological... Ribociclib	12 Years -	OHSU Knight Cancer Institute
Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall	NCT03651375	Sarcoma Fibrosarcoma Leiomyosarcoma Liposarcoma Myosarcoma Histiocytic Sar... Synovial Sarcom... Lymphangiosarco... Malignant Perip... Myxofibrosarcom... Myxoid Liposarc... Undifferentiate... Pleomorphic Lip... Undifferentiate... Dedifferentiate... Pleomorphic Rha... Malignant Trito...	Sequential chem... Hypofractionate...	18 Years - 100 Years	Maria Sklodowska-Curie National Research Institute of Oncology

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: